SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0000947871-05-002180
Filing Date
2005-12-07
Accepted
2005-12-06 19:41:10
Documents
1

Document Format Files

Seq Description Document Type Size
1 SCHDULE 13 D/A (ORBIMED ISLAY) sc13da_120605-biocryst.txt SC 13D/A 27479
  Complete submission text file 0000947871-05-002180.txt   29259
Mailing Address 2190 PARKWAY LAKE DR BIRMINGHAM AL 35244
Business Address 2190 PARKWAY LAKE DR BIRMINGHAM AL 35244 2054444600
BIOCRYST PHARMACEUTICALS INC (Subject) CIK: 0000882796 (see all company filings)

IRS No.: 621413174 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-44055 | Film No.: 051248285
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address
Business Address 787 THIRD AVE NEW YORK NY 10010 2127396400
ISALY SAMUEL D (Filed by) CIK: 0001055949 (see all company filings)

Type: SC 13D/A